Johnson L. David's most recent trade in Vera Therapeutics Inc - Ordinary Shares - Class A was a trade of 2,579 Class A Common Stock done at an average price of $42.0 . Disclosure was reported to the exchange on Feb. 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vera Therapeutics Inc (Class A) | David L. Johnson | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 41.98 per share. | 23 Feb 2026 | 2,579 | 45,727 | - | 42.0 | 108,276 | Class A Common Stock |
| Caribou Biosciences Inc | David L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2026 | 45,000 | 45,000 | - | - | Option to purchase Common Stock | |
| Vera Therapeutics Inc (Class A) | David L. Johnson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | David L. Johnson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 20,000 | 48,306 | - | 0 | Class A Common Stock | |
| Caribou Biosciences Inc | David L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Vera Therapeutics Inc (Class A) | David L. Johnson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 53,800 | 53,800 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc (Class A) | David L. Johnson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 26,900 | 26,900 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc (Class A) | David L. Johnson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 160,000 | 160,000 | - | - | Stock Option (right to buy) | |
| Caribou Biosciences Inc | Johnson L. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 39,500 | 39,500 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | David L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 21,500 | 21,500 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | David L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 44,000 | 44,000 | - | - | Option to purchase Common Stock |